| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/05/2001 | CN1070378C Medicine for curing hepatitis B |
| 09/05/2001 | CN1070375C Emulsion for lowering blood-lipid, and method for preparing same |
| 09/05/2001 | CN1070374C Traditional Chinese medicinal prepn. for treating various kinds of pustule, lump and ulceration |
| 09/05/2001 | CN1070373C Health-care oral liquid-contg. the fruit of Chinese wolfberry and prepn. method therefor |
| 09/05/2001 | CN1070372C Powerful anti-cancer plaster and its prepn. method |
| 09/05/2001 | CN1070371C Medicine for treating HIV-seropositive individuals medicine |
| 09/04/2001 | US6284880 A dna molecule coding for a gene that has anti-apoptotic effects; for transfection of eukaryotic cells without toxic effects |
| 09/04/2001 | US6284781 Anticancer agent |
| 09/04/2001 | US6284743 Method for modulating smooth muscle cell proliferation |
| 09/04/2001 | US6284742 Administering adenovirus and antibodies |
| 09/04/2001 | US6284740 Osteoprotegerin |
| 09/04/2001 | US6284728 Osteoprotegerin |
| 09/04/2001 | US6284539 Method for generating dopaminergic cells derived from neural precursors |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284485 Nucleic acids encoding osteoprotegerin |
| 09/04/2001 | US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals |
| 09/04/2001 | US6284285 Tissue repair promoting composition |
| 09/04/2001 | US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/04/2001 | US6284252 Transdominant TAT variants of the human immunodeficiency virus |
| 09/04/2001 | US6284245 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 09/04/2001 | US6284243 Physiologically functional food having brain function-improving, learning ability-enhancing, and memory-enhancing functions |
| 09/04/2001 | US6284242 Method for enhancing myoblast migration and invasion in the context of gene therapy |
| 09/04/2001 | US6284240 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 09/04/2001 | US6284239 Murine model for human carcinoma |
| 09/04/2001 | CA2205430C Method for making a medicament for treating secondary immunodeficiency |
| 09/02/2001 | CA2299956A1 Shark cartilage extract: process of making, methods of using and compositions thereof |
| 08/30/2001 | WO2001063286A2 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062931A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 08/30/2001 | WO2001062920A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | WO2001062902A1 Hybrid cell vaccines |
| 08/30/2001 | WO2001062901A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 08/30/2001 | WO2001062898A1 Artificial pancreatic islet reconstituted from isolated pancreatic endocrine cells |
| 08/30/2001 | WO2001062897A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines |
| 08/30/2001 | WO2001062895A2 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001062239A2 Novel compositions and uses of dictyostatin compounds |
| 08/30/2001 | WO2001062086A1 Nutritional intervention composition for enhancing and extending satiety |
| 08/30/2001 | WO2001024842A3 Hybrid matrices and hybrid matrix mixtures |
| 08/30/2001 | WO2001013927A3 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 08/30/2001 | WO2001012236A3 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 08/30/2001 | WO2001009325A3 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/30/2001 | WO2001002540A3 Adenoviral vectors for treating disease |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | US20010018427 Anticholesterol agent |
| 08/30/2001 | US20010018422 Anticancer agents |
| 08/30/2001 | US20010018419 Isolated and purified; Rh antigens which can be immobilized and used in hematology, for isolation and purification of anti-Rh antibodies from solutions; useful in treatment of hemolytic disease of newborn |
| 08/30/2001 | US20010018210 Contacting cells with dipeptidyl peptidase inhibitor immobilized by attachment to container or magetic particle or as part of heteroconjugate with antigenic peptide |
| 08/30/2001 | US20010018058 Isolated polypeptide comprising an immunogenic portion of a breast protein comprising an amino acid sequence encoded by a polynucleotide |
| 08/30/2001 | US20010018057 Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system |
| 08/30/2001 | DE10008279A1 Synergistic medicinal or health-promoting food additive composition, comprising lactose, inulin and/or oligofructose, calcium salt and Bifidus bacteria, having e.g. immunostimulant and digestion improving action |
| 08/30/2001 | CA2683009A1 Use of il-18 inhibitors |
| 08/30/2001 | CA2406864A1 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | CA2401070A1 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | CA2400896A1 Novel compositions and uses of dictyostatin compounds |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400838A1 Novel method for down-regulation of amyloid |
| 08/30/2001 | CA2400636A1 Hybrid cell vaccines |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400485A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 08/30/2001 | CA2399298A1 Use of il-18 inhibitors |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127581A1 Malleable paste for filling bone defects |
| 08/29/2001 | EP1127577A2 Ligand for the c-kit receptor and methods of use thereof |
| 08/29/2001 | EP1127576A1 Uses of NM23-polypeptides in skin and intestinal disorders |
| 08/29/2001 | EP1127151A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 08/29/2001 | EP1127150A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 08/29/2001 | EP1127149A2 Cells for the production of helper dependent adenoviral vectors |
| 08/29/2001 | EP1127134A1 Rotavirus subunit vaccine |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127109A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 08/29/2001 | EP1127107A1 Methods for the production of tcr gamma delta t cells |
| 08/29/2001 | EP1127075A2 A method of treating tumors using fas-induced apoptosis |
| 08/29/2001 | EP1127072A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 08/29/2001 | EP1127068A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 08/29/2001 | EP1126873A1 Method for enhancing proliferation of inner ear hair cells using ligands for her2 and/or her3 receptors |
| 08/29/2001 | EP1126872A1 CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT |
| 08/29/2001 | EP1126860A2 Immunomodulatory factors for immunosuppressant and antiallergic treatment |
| 08/29/2001 | EP1126859A2 Blood leucocyte apheresis for treatment of disease |
| 08/29/2001 | EP1126858A1 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 08/29/2001 | EP0914043A4 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | CN1310765A Mutant herpes simplex viruses and uses thereof |
| 08/29/2001 | CN1310227A Health food and its production process |
| 08/29/2001 | CN1310022A Method of making medicine from extracting metabolic product of staphylococcus aureus and thallus protein |
| 08/29/2001 | CN1310021A Health giving and face nursing composition of natural material |
| 08/29/2001 | CN1310020A Medicine for preventing and treating radiation damage of central nervous system |
| 08/29/2001 | CN1310013A Medicine for treating cardiovascular damage caused by systematic lupus erythematosus |
| 08/29/2001 | CN1310012A Medicine for treating fever caused by lupus erythematosus and other immunological disease |
| 08/29/2001 | CN1310009A Medicine for treating leucocytopenia caused by lupus erythematosus |
| 08/29/2001 | CN1310008A Lupus erythematosus treating medicine |
| 08/29/2001 | CN1310007A Detoxicating and recovering medicine powder |
| 08/29/2001 | CN1310006A Medicine for treating purpura caused by lupus erythematosus and other immunological disease |
| 08/29/2001 | CN1310005A External-use Chinese medicine plaster |
| 08/29/2001 | CN1310003A Combined Chinese and Western medicine for treating pulmonary emphysema |
| 08/29/2001 | CN1310002A Combined Chinese and Western medicine for treating bronchial asthma |
| 08/29/2001 | CN1310001A Combined Chinese and Western medicine for treating chronic bronchitis in catabasis |
| 08/29/2001 | CN1310000A Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis |